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CZT-1Xanthones are a class of heterocyclic compounds characterized by a dibenzo-γ-pyrone nucleus. Analysis of their
mode of action in cells, namely uncovering alterations in gene expression, is important because these compounds
have potential therapeutic applications. Thus, we studied the transcriptional response of the ﬁlamentous fungus
Neurospora crassa to a group of synthetic (thio)xanthone derivativeswith antitumor activity using high through-
put RNA sequencing. The induction of ABC transporters in N. crassa, particularly atrb and cdr4, is a common con-
sequence of the treatment with xanthones. In addition, we found a group of genes repressed by all of the tested
(thio)xanthone derivatives, that are evocative of genes downregulated during oxidative stress. The transcription-
al response of N. crassa treated with an acetophenone isolated from the soil fungus Neosartorya siamensis shares
some features with the (thio)xanthone-elicited gene expression proﬁles. Two of the (thio)xanthone derivatives
and theN. siamensis-derived acetophenone inhibited the growth of N. crassa. Our work also provides framework
datasets that may orientate future studies on the mechanisms of action of some groups of xanthones.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Xanthones are a class of heterocyclic compounds characterized by a
dibenzo-γ-pyrone nucleus [1–7]. They are composed by a unique chemi-
cal scaffold, the tricyclic aromatic system (C6–C3–C6) named xanthene-9-
one [2,5,7]. They are commonly found as secondarymetabolites in higher
plants, fungi and lichens [8], and can be obtained by synthetic methods
[9]. This class of compounds is composed by a rigid heteroaromatic tricy-
clic platform which may be considered as a ‘privileged structure’ since it
can provide different ligands through modiﬁcation of functional groups,
allowing them to interact with a large variety of biological targets [10].
The biological activity of xanthones and their derivatives is based on
their tricyclic scaffold but depends on the nature and position of the dif-
ferent substituents [2]. Since xanthones may play a role as anti-obial Biology Department, The
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. This is an open access article underproliferative and pro-apoptotic agents [2,11-14], several derivatives, in-
cluding (thio)xanthone derivatives, have been synthesized and tested in
human cancer cell lines [14,15], but not in fungi. It is thus important to
adddata fromdifferent organisms to the current knowledge on themech-
anism of action of xanthones.
XP13 (3,4-dihydro-12-hydroxy-2,2-dimethyl-2H,6H-pyrano
[3,2-b]-xanthen-6-one) (Fig. 1) is a prenylated analogue of 3,4-
dihydroxyxanth-9-one [11,13]. XP13 was shown to possess very po-
tent anticancer activity in leukemia [11] and breast cancer [13] cells.
XP13 was also shown to reduce cell proliferation, arrest the cell cycle
at the S phase and induce apoptosis [11]. In addition, XP13 was
shown to inhibit the interaction of p53 with MDM2 and mimicked
the activity of known p53 activators, leading to the activation of
p53-dependent transcriptional activity [16].
In this work, we have also tested the effects of three thioxanthone
derivatives on N. crassa—TX129 (1-[(3,4-dimethoxybenzyl)amino]-
4-propoxy-9H-thioxanthen-9-one), TX34 (1-(piperidin-1-yl)-4-
propoxy-9H-thioxanthen-9-one) and TX87 (1-{[2-(1,3-benzodioxol-5-
yl)ethyl]amino}-4-propoxy-9H-thioxanthen-9-one) (Fig. 1). These
compounds are aminated thioxanthones and were obtained by syn-
thesis after being designed to inhibit cancer cell proliferation andthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Chemical structures of the compounds used in this study. TX129: 1-[(3,4-dimethoxybenzyl)amino]-4-propoxy-9H-thioxanthen-9-one; TX34: 1-(piperidin-1-yl)-4-propoxy-9H-
thioxanthen-9-one; TX87: 1-{[2-(1,3-benzodioxol-5-yl)ethyl]amino}-4-propoxy-9H-thioxanthen-9-one; XP13: 3,4-dihydro-12-hydroyi-2,2-dimethyl-2H,6Hpyrano [3,2-b]-xanthen-6-one,
D1: 2,4-dihydroxy-3-methylacetophenone.
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obtained by merging the structural skeleton of thioxanthones with
moieties important for P-glycoprotein modulation [17]. TX34 has
been shown to behave as a non-competitive inhibitor of the P-
glycoprotein and to block the growth of cancer cells in vitro [15,17].
Herewe used the ﬁlamentous fungusN. crassa as amodel to study the
transcriptional response to a group of synthetic (thio)xanthone deriva-
tives using high-throughput RNA sequencing (RNA-seq) to assess alter-
ations in gene expression. Our data suggest that, in N. crassa, some ABC
transporter-encoding genes and the transcription factor czt-1 are induced
by different (thio)xanthone derivatives and that a group of genes – the
majority of which encode currently uncharacterized proteins – are re-
pressed by all of the tested compounds. XP13 (3,4-dihydro-12-hydroxy-
2,2-dimethyl-2H,6H-pyrano [3,2-b]-xanthen-6-one) led to the strongest
transcriptional response and growth impairment ofN. crassa. The present
study is the ﬁrst to describe the effects of (thio)xanthones in fungi and
will be important to understand their mechanism of action.
Material and methods
Strains, culture media and compounds
Standard procedures for the handling of wild type N. crassa cells
(FGSC 2489) were employed [18]. Cells were grown in Vogel'sMM sup-
plemented with 1.5% (w/v) sucrose [19]. Agar at 1.5% (w/v) concentra-
tion was added to obtain solid medium. Conidia were harvested by
the addition of sterile dH2O, agitation and ﬁltration through cheesecloth
in 7-day cultures on Vogel's MMwith agar at 26 °C.
The xanthone XP13 and the thioxanthones TX34, TX87, and TX129
were synthesized according to previously described procedures [11,
17]. The purity of each compound was determined by HPLC–DAD anal-
ysis using an isocratic elution of MeOH:H2O basiﬁed with TEA (1%) oracidiﬁed with CH3COOH (1%) at a constant ﬂow rate of 1.0 ml/min. All
tested compounds possessed a purity of at least 95%. (Thio)xanthone
derivatives and 2,4-dihydroxy-3-methylacetophenone (D1) were dis-
solved in DMSO (Sigma-Aldrich).RNA sequencing (RNA-seq)
Conidial suspensions at 1 × 106 cells/ml were incubated in minimal
medium for 6 h (26 °C, 140 rpm, constant light), followed by the addi-
tion of the indicated compounds (or the DMSO control solvent) for 1
more hour. Cells were harvested using 0.45 μm ﬁlters and immediately
frozen in liquid nitrogen. Total RNA was isolated by the Trizol–Phenol–
Chloroform method, three times for control samples and once for the
treatmentswith (thio)xanthones and the acetophenone. After digestion
of 25 μg RNA with TURBO DNAse (Life Technologies), mRNA was puri-
ﬁed using Dynabeads oligo(dT) magnetic beads (Life Technologies).
ThemRNAwas chemically fragmented using the Ambion RNA fragmen-
tation kit (Life Technologies). First and second strand cDNA synthesis
was achieved using appropriate kits (Life Technologies). The Illumina
TruSeq kit was employed to generate the cDNA libraries with indexing
adapters essentially following the manufacturer's protocol. After puriﬁ-
cation of the libraries with AMPure XP beads (Roche), the quality of the
libraries was analyzed in an Agilent 2100 Bioanalyzer. The cDNA librar-
ies were sequenced in an Illumina HiSeq2000 and single reads of 50 bp
were obtained. Sequencing data was handled essentially with Tophat,
Cufﬂinks and Cuffdiff [20]. Expression levels are presented as Frag-
ments/Reads Per Kilobase of transcript per Million mapped reads
(FPKM/RPKM). The resulting dataset is available at the NCBI GEO data-
base (http://www.ncbi.nlm.nih.gov/geo/; series record: GSE53040).
Functional enrichment of sets of genes was assessed with FunCat [21]
and Venn diagrams were obtained using Venny [22].
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For growth assessment in liquid Vogel's MM, 1 × 104 conidia/ml
were incubated at 26 °C, 100 rpm, under constant light in 96-well plates
(200 μl/well) and absorbance at 620 nm [23] was followed (Thermo
Electron CorporationMultiskan EX) during 24 h. At least three indepen-
dent experiments were performed in each case. The Mann–Whitney
statistical test was used to make comparisons between conditions.
Results and discussion
Transcriptional proﬁling and functional enrichment analyses of the
N. crassa response to (thio)xanthone derivatives
N. crassa cells were grown for 6 h in liquid Vogel's medium, treated
for 1 h with 20 μM of each of the (thio)xanthone derivatives TX129,
TX34, TX87 and XP13 (Fig. 1), and processed for RNA-seq. Treatment
with the different compounds led to an alteration of the expressionFig. 2.Overview of theN. crassa transcriptional response to (thio)xanthone derivatives and a se
upon treatment with each of the indicated compounds (left panel; yellow: altered genes; grey
induced genes; grey: repressed genes) was calculated for cells treated with TX129 (i), TX34 (i
(thio)xanthone-speciﬁc repressed (i) and induced (ii) genes. * and # indicate genes that are eilevels of a signiﬁcantly different fraction of genes (Supplemental File
1). XP13was the xanthonederivative eliciting themost active transcrip-
tional response, altering the expression of 15.7% of the genes (Fig. 2A, i–
iv, left panels). TX34, TX87 and TX129 modiﬁed the expression of 3.5,
1.1 and 0.6% of the genes, respectively. As a comparison, a 1-hour treat-
ment with 20 μM staurosporine, a protein kinase inhibitor that induces
cell death in N. crassa, causes the alteration of approximately 20% of the
genes [24]. Interestingly, all the (thio)xanthone derivatives caused a
large downregulation of gene expression, particularly TX87 and XP13,
with 94.5% and 88.4% of repressed genes among those with altered ex-
pression (Fig. 1A, i–iv, right panels). These data indicate that treatment
with (thio)xanthone derivativesmainly leads to the decrease in expres-
sion levels of N. crassa genes, which is considerably different from the
fungal response to staurosporine, which causes a similar percentage of
gene induction and repression [24].
FunCat [21] was employed to evaluate if there were enriched func-
tional categories among datasets of genes which showed increased or
reduced expression levels for each compound (Supplemental File 2condarymetabolite fromN. siamensis. (A) The percentage of genes with altered expression
: unaltered genes) and the fraction of induced and repressed genes (right panel; yellow:
i), TX87 (iii), XP13 (iv) and D1 (v). (B) Venn diagrams were used to assess the amount of
ther repressed or induced by all of the tested (thio)xanthone derivatives, respectively.
Table 1
Functional enrichment analysis of genes whose expression was altered by the (thio)xanthone derivatives (P-value b0.0001).
FunCat ID Category P-value
TX129 (induced genes)
32.01.01 Oxidative stress response 1.99E− 05
32.05.01 Resistance proteins 4.82E− 05
32.07 Detoxiﬁcation 1.28E− 05
TX34 (induced genes)
1 Metabolism 2.21E− 14
01.05 C-compound and carbohydrate metabolism 2.84E− 05
01.06 Lipid, fatty acid and isoprenoid metabolism 2.01E− 08
20.01.01 Ion tranport 8.37E− 05
20.01.01.01 Cation transport (H+, Na+, K+, Ca2+, NH4+, etc.) 2.28E− 05
20.03.22 Transport ATPases 2.48E− 07
20.09.16.01 Type I protein secretion system (ABC-type transport systems) 4.96E− 06
32.05.01 Resistance proteins 1.51E− 05
34.01 Homeostasis 5.09E− 05
34.01.01 Homeostasis of cations 2.33E− 05
34.01.01.01 Homeostasis of metal ions (Na, K, Ca etc.) 1.96E− 06
XP13 (induced genes)
1 Metabolism 1.29E− 07
01.05 C-compound and carbohydrate metabolism 6.58E− 06
2 Energy 1.42E− 06
20.01.01 Ion transport 6.58E− 06
20.01.27 Drug/toxin transport 1.07E− 05
20.03.22 Transport ATPases 4.32E− 07
20.03.25 ABC transporters 7.67E− 05
20.09.16.01 Type I protein secretion system (ABC-type transport systems) 3.16E− 05
32 Cell rescue, defense and virulence 3.78E− 09
32.01.01 Oxidative stress response 2.01E− 07
32.07 Detoxiﬁcation 1.92E− 13
32.07.05 Detoxiﬁcation by export 5.63E− 06
32.07.07 Oxygen and radical detoxiﬁcation 2.07E− 05
XP13 (repressed genes)
10 Cell cycle and DNA processing 2.54E− 07
10.03 Cell cycle 1.57E− 05
10.03.01 Mitotic cell cycle and cell cycle control 8.94E− 06
11 Transcription 4.17E− 13
11.02 RNA synthesis 9.80E− 08
11.02.03 mRNA synthesis 4.04E− 06
11.02.03.04 Transcriptional control 4.06E− 07
11.04 RNA processing 1.47E− 05
11.04.01 rRNA processing 1.43E− 07
16.03 Nucleic acid binding 3.42E− 05
18.02.05 Regulator of G-protein signaling 9.64E− 05
20.09 Transport routes 6.46E− 05
29A. Pedro Gonçalves et al. / Genomics Data 4 (2015) 26–32and Table 1). The dataset of TX129-induced genes was enriched inmol-
ecules involved in the response to oxidative stress and in resistance and
detoxiﬁcation. In turn, TX34 induced genes involved in metabolism
(carbon, carbohydrate and lipid metabolism) and in ion transport and
homeostasis. The FunCat analysis was particularly useful in the case of
XP13-altered genes. The XP13-induced dataset was highly enriched in
genes involved in cell rescue, defense and virulence (namely genes re-
lated with detoxiﬁcation by members of the ABC transporter familyTable 2
Genes that are repressed (*) and induced (#) by all of the tested (thio)xanthone derivatives an
Shared genes FPKM
DMSO TX129 TX34
NCU04907 ⁎ 56.17 22.52 (0.40) 13.86 (0.25)
NCU00999 ⁎ 65.75 25.78 (0.39) 13.65 (0.21)
NCU07235 ⁎ 14.72 4.89 (0.33) 1.36 (0.09)
NCU11307 ⁎ 65.40 29.14 (0.45) 20.47 (0.31)
NCU09020 ⁎ 11.89 4.13 (0.35) 3.96 (0.33)
NCU09428 ⁎ 5.67 0.89 (0.16) 1.16 (0.20)
NCU04910 ⁎ 85.13 25.19 (0.30) 26.93 (0.32)
NCU11922 ⁎ 35.84 8.82 (0.25) 4.41 (0.12)
NCU02098 ⁎ 48.30 17.72 (0.37) 9.38 (0.19)
NCU09830 # 2.31 342.31 (148.19) 427.86 (185.22
Fold change versus control (DMSO) is indicated between parentheses. ns: not signiﬁcant.and genes implicated in the response to oxidative stress) and in genes
implicated in metabolism and energy. On the other hand, XP13-
repressed genes seem to be related to cell cycle and RNA synthesis
and processing. The latter feature is sharedwith staurosporine [24], sug-
gesting that some pathways may be disturbed by both compounds.
Venn diagrams were built in order to evaluate whether repressed or
induced genes were shared between the (thio)xanthone derivatives.
For most of the genes, the alteration in expression levels elicited byd the respective FPKM.
TX87 XP13 D1
23.56 (0.42) 14.85 (0.26) 16.02 (0.29)
24.39 (0.37) 25.60 (0.39) 50.77 (0.77, ns)
5.06 (0.34) 1.22 (0.08) 4.57 (0.31)
15.30 (0.23) 20.00 (0.31) 26.42 (0.40)
4.06 (0.34) 0.93 (0.08) 6.41 (0.54, ns)
1.50 (0.26) 0.54 (0.10) 1.02 (0.18)
26.09 (0.31) 34.94 (0.41) 31.90 (0.37)
14.70 (0.41) 5.61 (0.16) 10.08 (0.28)
22.13 (0.46) 6.04 (0.13) 37.14 (0.77, ns)
) 99.49 (43.07) 357.96 (154.96) 11.46 (4.96)
Table 3
Annotation details of genes that are repressed (*) and induced (#) by all of the tested (thio)xanthone derivatives.
Gene Annotation a Conserved domains a Observations a STS [24] b PHS [25] c MENA [26] d
NCU04907 Hypothetical protein Methyltransferase domain Oxidative stress Down Down Down
NCU00999 Hypothetical protein
NCU07235 Hypothetical protein Down
NCU11307 CCC1 VIT family Iron homeostasis; vacuolar
iron transporter; oxidative stress
Down Up
NCU09020 Hypothetical protein C4-dicarboxylate transporter/malic
acid transport protein
Down
NCU09428 Hypothetical protein Oxidative stress Down Down
NCU04910 Hypothetical protein Methyltransferase domain Oxidative stress Down Down Down
NCU11922 Hypothetical protein Also annotated as NCU16555 Down Down
NCU02098 G/U mismatch-speciﬁc
DNA glycosylase
Uracil DNA glycosylase superfamily;
Mismatch-speciﬁc thymine-DNA glycosylate
Base-excision repair;
oxidative stress
Down
NCU09830 ABC multidrug transporter ABC transporter Oxidative stress Up e
STS: staurosporine, PHS: phytosphingosine, MENA: menadione.
a N. crassa database at the Broad Institute (www.broadinstitute.org/annotation/genome/neurospora/MultiHome.html).
b The dataset was obtained by RNA-seq.
c The dataset was obtained by microarray analysis.
d The dataset was obtained by digital gene expression proﬁling.
e NCU09830 was the gene with the highest induction by menadione.
30 A. Pedro Gonçalves et al. / Genomics Data 4 (2015) 26–32the (thio)xanthone derivatives was drug-speciﬁc (Fig. 2A–B). However,
nine genes (Fig. 2B, i, marked with *) were repressed by all of the
(thio)xanthone derivatives – NCU04907, NCU00999, NCU07235,
NCU11307, NCU09020, NCU09428, NCU04910, NCU11922, and
NCU02098 – and one gene (Fig. 2B, ii, marked with #) was induced by
all of them—NCU09830. Table 2 presents the FPKMs for these genes in
control- as well as in (thio)xanthone-treated cells and Table 3 describes
their annotation. The function of the majority of these proteins is still
unknown and they are all annotated as ‘hypothetical proteins’. Howev-
er, based on previous transcription proﬁling work, we noticed a clear
trend that indicates that some of these genes are involved in oxidative
stress because, as in the case of the (thio)xanthone derivatives, they
were either repressed – NCU04907, NCU09428, NCU04910 and
NCU02098 – or induced – NCU09830 – by different oxidative stress in-
ducers, namely staurosporine, phytosphingosine and menadione
[24-27]. Thus, the results suggest that xanthone derivatives affect the
cellularmachinery that is implicated in the response to oxidative stress.
In addition, we observed that among the nine genes repressed by all of
the tested (thio)xanthone derivatives, two encode proteins that harbor
a methyltransferase domain, suggesting that proteins that possess this
functional domain may be involved in the mechanism of action of this
type of compounds.
We have recently characterized CZT-1, a transcription factor
encoded by NCU09974 that is involved in staurosporine-induced cellFig. 3. (Thio)xanthone derivatives induce the expression of czt-1 and of different members of th
N. crassa cells treated with TX34, XP13 (or DMSO) are presented. (B) The levels of expression
NCU04161 in N. crassa cells treated with the (thio)xanthone derivatives were obtained and thdeath in N. crassa [24]. Treatment with TX34 and XP13 also led to a
strong induction of czt-1 (Fig. 3A), further emphasizing its role in the re-
sponse to cellular stress. In addition, NCU07235, NCU11307, NCU09020
and NCU11992, genes whose expression is repressed by all of the
(thio)xanthone derivatives, are strongly repressed in a Δczt-1 deletion
mutant [24], suggesting that these genes are under the regulatory con-
trol of the CZT-1 transcription factor.Analysis of ABC transporter-encoding genes in the (thio)xanthone-treated
gene expression datasets
We compiled a list of described and predicted ABC transporter-
encoding genes in N. crassa and analyzed their expression levels upon
treatment with the (thio)xanthone derivatives. Interestingly, we found
that some genes encoding ABC transporters increased in expression
level upon treatment with different (thio)xanthone derivatives. Besides
NCU09830 (induced by all of the tested (thio)xanthone derivatives), we
also observed that NCU05591 (induced by TX129, TX34 and XP13),
NCU07546 and NCU09975 (induced by TX34 and XP13) and NCU04161
(induced by XP13) were induced by more than one of the compounds
(Fig. 3B). Thus, our data indicate that NCU09830, NCU05591 and other
ABC transporter-encoding genes appear to be an important target for
xanthones in N. crassa.e ABC transporter family. (A) The levels of expression (in FPKMs) of NCU09974 (czt-1) in
(in FPKMs) of NCU09830 (atrb), NCU05591 (cdr4), NCU07546, NCU09975 (abc-3) and
e fold change versus the control (DMSO) was calculated. *, P-value b0.05.
Table 4
Functional enrichment analysis of genes whose expression was altered by D1 (P-value
b0.0001).
FunCat ID Category P-value
D1 (induced genes)
1 Metabolism 1.41E− 05
01.05 C-compound and carbohydrate metabolism 1.70E− 05
02.16 Fermentation 3.89E− 05
32.01.01 Oxidative stress response 2.48E− 05
32.07 Detoxiﬁcation 9.99E− 08
D1 (repressed genes)
1 Metabolism 2.89E− 07
01.01 Amino acid metabolism 1.27E− 07
01.01.06 Metabolism of the aspartate family 2.69E− 06
01.02 Nitrogen, sulfur and selenium metabolism 3.97E− 05
01.03.01 Purine nucleotide/nucleoside/nucleobase metabolism 4.14E− 05
01.05.13 Transfer of activated C-groups 6.39E− 05
01.05.13.03 Tetrahydrofolate-dependent C-transfer 7.71E− 06
31A. Pedro Gonçalves et al. / Genomics Data 4 (2015) 26–32NCU09830 and NCU05591 encode ATRB and CDR4, respectively, and
share high similarity with ABC transporters of the pleiotropic drug resis-
tance (PDR) subfamily [28]. In N. crassa, ATRB was found in a group of
menadione-induced genes [27] while CDR4 is an important mediator of
resistance to azole drugs [28]. NCU09975 and NCU07546 are ABC trans-
porters that belong to the multidrug resistance (MDR) subfamily.
NCU09975 encodes ABC-3, an ABC transporter that performs the efﬂux
of staurosporine in N. crassa [29,30]. NCU04161 is an ABC transporterFig. 4.Growth of N. crassa cells in the presence of the (thio)xanthone derivatives and the N. siam
620 nmof N. crassa cells in culturemedium supplemented with TX129 (A), TX34 (B), TX87 (C),
the 24 hour time point is presented. *, P-value b0.05.that belongs to the multidrug resistance-associated protein (MRP) sub-
family. Interestingly, the transcription factor CZT-1 regulates the ex-
pression of NCU09975, NCU07546 and NCU05591 [24], indicating
that it may have an important role during the fungal response to
(thio)xanthones.
The fungal secondary metabolite 2,4-dihydroxy-3-methylacetophenone
elicits a deﬁned transcriptional response in N. crassa
We also evaluated the transcriptional response of N. crassa cells to
2,4-dihydroxy-3-methylacetophenone (termed ‘D1’ from now on)
(Fig. 1), a secondarymetabolite from the culture ofNeosartorya siamensis
KUFC 6349 collected from soil in Thailand [31]. A 1-hour treatment of
N. crassa cells with 20 μMD1 resulted in the alteration of the expression
levels of 3.5% of the genes (Fig. 2A, v, left panel), which is comparable
with the TX34 proﬁle. D1 caused a similar fraction of gene induction
and repression (Fig. 2A, v, right panel). Functional enrichment among
the genes that were either induced or repressed by D1 was evaluated
using FunCat (Supplemental File 2 and Table 4). D1 induced genes in-
volved in carbon compound and carbohydrate metabolism, fermenta-
tion, oxidative stress response and detoxiﬁcation (Table 4), indicating
an active response of the fungus in the presence of this compound. In
fact, analysis of the genes included in the ‘detoxiﬁcation’ category re-
vealed that D1 led to the upregulation of geneswithin the ABC transport-
er family, namely NCU05591 (cdr4), NCU07546 and NCU09830 (atrb),
which is a shared feature with some of the aforementioned xanthoneensis-derived compound D1. (A-E) Growthwas evaluated by following the absorbance at
XP13 (D) and D1 (E). (F) The percentage of inhibition caused by each of the compounds at
32 A. Pedro Gonçalves et al. / Genomics Data 4 (2015) 26–32derivatives. Among the repressed genes, there was an enrichment of
genes involved in several categories relatedwith cellmetabolism, includ-
ing metabolism of aspartate, nitrogen, sulfur, selenium, purines and tet-
rahydrofolate (Table 4). Interestingly, also like the tested (thio)xanthone
derivatives, D1 led to the repression of NCU04907, NCU07235,
NCU11307, NCU09428, NCU04910 and NCU11922 (Table 2), suggesting
that D1 and (thio)xanthones activate common intracellular pathways
and further emphasizes that the downregulation of these genes is related
to a fungal stress response.
(Thio)xanthone derivatives and D1 inhibit the growth of N. crassa
Previous reports have shown that xanthone derivatives possess anti-
proliferative and pro-apoptotic activity [2,11-14]. Thus, we evaluated
the growth ofN. crassa cells in the presence of the (thio)xanthonederiv-
atives and the acetophenone isolated from N. siamensis. TX129, XP13
and D1 markedly inhibited the growth of N. crassa while TX34 and
TX87 did not have a signiﬁcant impact on growth (see curves in
Fig. 4A–E and quantiﬁcation of the data for the 24 hour time point in
Fig. 4F). Importantly, XP13 ranked ﬁrst as the compound causing the
most dynamic transcriptional response, altering the expression of ap-
proximately 16% of the N. crassa genes (Fig. 2A, iv). Thus, the aforemen-
tioned transcriptional alterations caused by the (thio)xanthone
derivatives TX129 and XP13 and the acetophenone D1 are associated
with an deleterious effect on fungal growth.
Conclusions
The availability of high-throughput methodologies to manipulate
simple models like N. crassa constitutes a major advantage to study
intracellular pathways that are targeted by exogenous compounds.
Our results pointed out that ABC transporters and a group of mostly
uncharacterized genes are targets of xanthone and acetophenone deriv-
atives, suggesting that they correspond to common fungal stress re-
sponse elements. In addition, our work provides several datasets that
may orientate future studies on the mechanisms underlying the inhibi-
tory effects on cell growth caused by xanthones.
Acknowledgments
A.P.G. was a recipient of a fellowship from Fundação Calouste
Gulbenkian (104210) and a short-term fellowship from EMBO
(329-2012). This work was supported by FCT Portugal (CEQUIMED-
PEst-OE/SAU/UI4040/2014, PEst-C/SAU/LA0002/2013 and FCOMP-
01-0124-FEDER-037277 to A.V.), the European POCI program of
QCAIII co-participated by FEDER (NORTE-07-0124-FEDER-000003),
a grant from the National Institutes of Health (NIH R24 GM081597
to N.L.G. with Drs. JW Taylor and RB Brem) and project MARBIOTECH
(NORTE-07-0124-FEDER-000047) within the SR&TD Integrated Pro-
gram MARVALOR—Building research and innovation capacity for im-
proved management and valorization of marine resources, supported
by the Programa Operacional Regional do Norte (ON.2—O Novo
Norte) and by the European Regional Development Fund.
Appendix A. Supplementary data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.gdata.2015.02.001.
References
[1] O. Mazimba, F. Nana, V. Kuete, G.S. Singh, 11—Xanthones and anthranoids from the
medicinal plants of Africa. in: V. Kuete (Ed.), Medicinal Plant Research in Africa,
Elsevier, Oxford, 2013, pp. 393–434.
[2] M.M. Pinto, M.E. Sousa, M.S. Nascimento, Xanthone derivatives: new insights in
biological activities. Curr. Med. Chem. 12 (2005) 2517–2538.[3] M. Pedro, F. Cerqueira, M.E. Sousa, M.S.J. Nascimento, M. Pinto, Xanthones as inhib-
itors of growth of human cancer cell lines and their effects on the proliferation of
human lymphocytes in vitro. Bioorg. Med. Chem. 10 (2002) 3725–3730.
[4] M. Pinto, R. Castanheiro, Natural prenylated xanthones: chemistry and biological ac-
tivities. in: G. Brahmachari (Ed.), Natural Products: Chemistry, Biochemistry and
Pharmacology, Alpha Science International, Oxford, UK, 2009.
[5] G.E. Brahmachari, Natural Products: Chemistry, Biochemistry and Pharmacology.
Alpha Science International, Oxford, UK, 2009.
[6] V.E. Kuete, Medicinal Plant Research in Africa: Pharmacology and Chemistry.
Elsevier, Oxford, UK, 2013.
[7] D. Obolskiy, I. Pischel, N. Siriwatanametanon, M. Heinrich, Garcinia mangostana L.: a
phytochemical and pharmacological review. Phytother. Res. 23 (2009) 1047–1065.
[8] L.M. Vieira, A. Kijjoa, Naturally-occurring xanthones: recent developments. Curr.
Med. Chem. 12 (2005) 2413–2446.
[9] C.M.G. Azevedo, C.M.M. Afonso, M.M.M. Pinto, Routes to xanthones: an update on
the synthetic approaches. Curr. Org. Chem. 16 (2012) 2818–2867.
[10] B. Lesch, S. Brase, A short, atom-economical entry to tetrahydroxanthenones.
Angew. Chem. 43 (2004) 115–118.
[11] A. Palmeira, A. Paiva, E. Sousa, H. Seca, G.M. Almeida, R.T. Lima, M.X. Fernandes, M.
Pinto, M.H. Vasconcelos, Insights into the in vitro antitumor mechanism of action
of a new pyranoxanthone. Chem. Biol. Drug Des. 76 (2010) 43–58.
[12] E. Costa, E. Sousa, N. Nazareth, M.S.J. Nascimento, M.M.M. Pinto, Synthesis of xan-
thones and benzophenones as inhibitors of tumor cell growth. Lett. Drug Des. Dis-
covery 7 (2010) 487–493.
[13] A.M. Paiva, M.E. Sousa, A. Camoes, M.S.J. Nascimento, M.M.M. Pinto, Prenylated xan-
thones: antiproliferative effects and enhancement of the growth inhibitory action of
4-hydroxytamoxifen in estrogen receptor-positive breast cancer cell line. Med.
Chem. Res. 21 (2012) 552–558.
[14] E. Sousa, A. Paiva, N. Nazareth, L. Gales, A.M. Damas, M.S.J. Nascimento, M. Pinto,
Bromoalkoxyxanthones as promising antitumor agents: synthesis, crystal structure
and effect on human tumor cell lines. Eur. J. Med. Chem. 44 (2009) 3830–3835.
[15] A. Palmeira, M.H. Vasconcelos, A. Paiva, M.X. Fernandes, M. Pinto, E. Sousa, Dual in-
hibitors of P-glycoprotein and tumor cell growth: (re)discovering thioxanthones.
Biochem. Pharmacol. 83 (2012) 57–68.
[16] M. Leao, C. Pereira, A. Bisio, Y. Ciribilli, A.M. Paiva, N. Machado, A. Palmeira, M.X.
Fernandes, E. Sousa, M. Pinto, A. Inga, L. Saraiva, Discovery of a new small-
molecule inhibitor of p53–MDM2 interaction using a yeast-based approach.
Biochem. Pharmacol. 85 (2013) 1234–1245.
[17] A. Palmeira, E. Sousa,M.X. Fernandes, M.M. Pinto, M.H. Vasconcelos, Multidrug resis-
tance reversal effects of aminated thioxanthones and interaction with cytochrome
P450 3A4. J. Pharm. Pharm. Sci. 15 (2012) 31–45.
[18] R.H. Davis, F.J. de Serres, Genetic and microbiological research techniques for Neu-
rospora crassa. Meth Enzymol. 17 (1970) 79–143.
[19] H.J. Vogel, A convenient growth medium for Neurospora (Medium N). Microbial
Genet. Bull. 13 (1956) 42–43.
[20] C. Trapnell, A. Roberts, L. Goff, G. Pertea, D. Kim, D.R. Kelley, H. Pimentel, S.L.
Salzberg, J.L. Rinn, L. Pachter, Differential gene and transcript expression analysis
of RNA-seq experiments with TopHat and Cufﬂinks. Nat. Protoc. 7 (2012) 562–578.
[21] A. Ruepp, A. Zollner, D. Maier, K. Albermann, J. Hani, M. Mokrejs, I. Tetko, U.
Guldener, G. Mannhaupt, M. Munsterkotter, H.W. Mewes, The FunCat, a functional
annotation scheme for systematic classiﬁcation of proteins from whole genomes.
Nucleic Acids Res. 32 (2004) 5539–5545.
[22] J.C. Oliveros, VENNY, An interactive tool for comparing lists with Venn Diagrams.
http://bioinfogp.cnb.csic.es/tools/venny/index.html2007.
[23] U. Binder, M. Chu, N.D. Read, F. Marx, The antifungal activity of the Penicillium
chrysogenum protein PAF disrupts calcium homeostasis in Neurospora crassa.
Eukaryot. Cell 9 (2010) 1374–1382.
[24] A.P. Goncalves, C. Hall, D.J. Kowbel, N.L. Glass, A. Videira, CZT-1 is a novel transcrip-
tion factor controlling cell death and natural drug resistance in Neurospora crassa.
G3 (4) (2014) 1091–1102.
[25] A. Videira, T. Kasuga, C. Tian, C. Lemos, A. Castro, N.L. Glass, Transcriptional analysis
of the response of Neurospora crassa to phytosphingosine reveals links to mitochon-
drial function. Microbiology 155 (2009) 3134–3141.
[26] J. Zhu, X. Yu, B. Xie, X. Gu, Z. Zhang, S. Li, Transcriptomic proﬁling-based mutant
screen reveals three new transcription factors mediating menadione resistance in
Neurospora crassa. Fungal Biol. 117 (2013) 422–430.
[27] M. Takahashi, K. Yamashita, A. Shiozawa, A. Ichiishi, F. Fukumori, M. Fujimura, An
AP-1-like transcription factor, NAP-1, regulates expression of the glutathione S-
transferase and NADH:ﬂavin oxidoreductase genes in Neurospora crassa. Biosci.
Biotechnol. Biochem. 74 (2010) 746–752.
[28] Y. Zhang, Z. Zhang, X. Zhang, H. Zhang, X. Sun, C. Hu, S. Li, CDR4 is the major contrib-
utor to azole resistance among four Pdr5p-like ABC transporters in Neurospora
crassa. Fungal Biol. 116 (2012) 848–854.
[29] A.S. Fernandes, A. Castro, A. Videira, Reduced glutathione export during pro-
grammed cell death of Neurospora crassa. Apoptosis 18 (2013) 940–948.
[30] A.S. Fernandes, A.P. Goncalves, A. Castro, T.A. Lopes, R. Gardner, N.L. Glass, A. Videira,
Modulation of fungal sensitivity to staurosporine by targeting proteins identiﬁed by
transcriptional proﬁling. Fungal Genet. Biol. 48 (2011) 1130–1138.
[31] S. Buttachon, A. Chandrapatya, L. Manoch, A. Silva, L. Gales, C. Bruyere, R. Kiss, A.
Kijjoa, Sartorymensin, a new indole alkaloid, and new analogues of tryptoquivaline
and ﬁscalins produced by Neosartorya siamensis (KUFC 6349). Tetrahedron 68
(2012) 3253–3262.
